CPhI preview – Almac: partnering to advance human health

Published: 24-Sep-2012 Featured companies: Almac Group
Regulatory

Almac provides a comprehensive range of integrated services from research through pharmaceutical and clinical development to commercialisation of product

Almac provides a comprehensive range of integrated services from research through pharmaceutical and clinical development to commercialisation of product.

New developments

At Almac’s global headquarters, $1m has been invested in a dedicated mass spectrometry lab, while expansion of its manufacturing capacity is underway. Reactor vessels with cleanroom product isolation and drying equipment will allow Highly Potent API manufacture up to 600kg batch size. Additionally, the company’s biocatalyst group has experienced growth in building block supply, evolution and commercial manufacture projects as well as metabolite synthesis.

Almac also recently dedicated $10m to a new non-GMP pharmaceutical development facility enhancing speed and flexibility to provide streamlined progression between development and GMP phases of projects. A further $10m investment was made in a stateof-the-art, 100,000ft2 facility in Audubon, PA now offering quality, flexible US commercial packaging solutions for solid oral and sterile biopharmaceutical drug products.

Hall 10 Stand E41

Featured companies

The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech...
See more

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

Read more
The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
  3. Highly potent APIs: Hazards in classification and handling This variability and subjective nature of classification means that the OEL is best considered as a tool for site risk management teams
  4. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey
  5. Solvent recycler SPR-200 boosts sustainability in pharma labs Recycling up to 90% of solvent in isocratic HPLC improves lab efficiency and sustainability

Relevant companies

See more

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA
Manufacturing

Almac completes “outstanding” grade by the KTP

The Innovate UK-funded KTP aimed to embed flow technologies to ensure long term security of supply for key raw materials through development
Manufacturing

Almac Sciences Ireland secures HPRA certification

This additional certification enables Almac to perform biologics testing for the determination of product quality attributes
Regulatory

Almac receives product approval by MHRA and Health Canada

The company’s site provides a range of solutions for blister packs, stickpacks, and kitting
Packaging

Enhancing clinical trial supply with JTM: part I

In a constantly changing world, the pharmaceutical industry is having to adopt its practices to serve the needs of a rapidly growing and ageing population and develop innovative personalised medicines. Almac has responded to these demands with a Just-in-Time Manufacturing solution that fulfils the requirements of a high value, time sensitive clinical supply chain. Dr Kevin Robinson spoke to Natalie Balanovsky, Just-in-Time Manufacturing Solutions Manager, and Mark Rohlfing, Vice President of Operations, to find out more
Regulatory

Almac welcomes confirmation that Northern Ireland will remain aligned with the EU post-Brexit

Move offers Almac clients unique, unfettered and flexible access to both the UK and European markets
Regulatory

Almac Group supports two COVID-19 clinical studies in sub-Saharan Africa

Grant awarded from the COVID-19 Therapeutics Accelerator, an Initiative by the Bill & Melinda Gates Foundation, Wellcome and Mastercard
Subscribe now